|
ES286422Y
(es)
*
|
1982-10-08 |
1986-09-16 |
Glaxo Group Limited |
Dispositivo para administrar medicamentos a pacientes
|
|
USD295787S
(en)
|
1985-05-13 |
1988-05-17 |
Hegemann Manfred K |
Nasal spray dispenser
|
|
SE453566B
(sv)
*
|
1986-03-07 |
1988-02-15 |
Draco Ab |
Anordning vid pulverinhalatorer
|
|
US4706663A
(en)
*
|
1986-04-25 |
1987-11-17 |
Makiej Paul A |
Particle catcher for inhalation devices
|
|
JPS63143081A
(ja)
*
|
1986-12-05 |
1988-06-15 |
メクト株式会社 |
吸入器
|
|
US5011044A
(en)
*
|
1987-07-02 |
1991-04-30 |
Brown Arlon R |
Anti-assault device
|
|
US5239991A
(en)
*
|
1989-06-21 |
1993-08-31 |
Fisons Plc |
Disposable powder medicament inhalation device with peel-off cover
|
|
MY105368A
(en)
*
|
1990-03-02 |
1994-09-30 |
Glaxo Group Ltd |
Inhalation device.
|
|
US5492112A
(en)
*
|
1991-05-20 |
1996-02-20 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US5301664A
(en)
*
|
1992-03-06 |
1994-04-12 |
Sievers Robert E |
Methods and apparatus for drug delivery using supercritical solutions
|
|
AU684754B2
(en)
*
|
1993-03-03 |
1998-01-08 |
Glaxo Wellcome Inc. |
Dry powder inhalator medicament carrier
|
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
|
US5699789A
(en)
*
|
1996-03-11 |
1997-12-23 |
Hendricks; Mark R. |
Dry powder inhaler
|
|
US5871010A
(en)
*
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
|
DE19835346A1
(de)
*
|
1998-08-05 |
2000-02-10 |
Boehringer Ingelheim Pharma |
Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
|
|
US6451289B2
(en)
|
2000-03-24 |
2002-09-17 |
Sepracor Inc. |
Albuterol formulations
|
|
US6596262B2
(en)
|
2001-02-15 |
2003-07-22 |
Aeropharm Technology Incorporated |
Modulated release particles for aerosol delivery
|
|
US6485707B2
(en)
|
2001-02-15 |
2002-11-26 |
Aeropharm Technology Incorporated |
Modulated release particles for aerosol delivery
|
|
EP1238680B1
(en)
*
|
2001-03-05 |
2003-12-10 |
Ivo Pera |
Inhaling device for dispersing powdered medicaments contained in a capsule through the respiratory tract
|
|
US6681768B2
(en)
|
2001-06-22 |
2004-01-27 |
Sofotec Gmbh & Co. Kg |
Powder formulation disintegrating system and method for dry powder inhalers
|
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
|
EP1587482A4
(en)
*
|
2003-01-31 |
2010-08-25 |
Technion Res & Dev Foundation |
INFLAMMATORY COMPOSITIONS AND ITS USES
|
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
|
TW200510298A
(en)
|
2003-06-13 |
2005-03-16 |
Theravance Inc |
Substituted pyrrolidine and related compounds
|
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
|
GB0329182D0
(en)
*
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7624733B2
(en)
*
|
2004-02-09 |
2009-12-01 |
Oriel Therapeutics, Inc. |
Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
|
|
TWI341836B
(en)
|
2004-03-11 |
2011-05-11 |
Theravance Inc |
Biphenyl compounds useful as muscarinic receptor antagonists
|
|
US20060120972A1
(en)
*
|
2004-11-09 |
2006-06-08 |
Peter Engels |
9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
|
|
DE102005001332A1
(de)
*
|
2005-01-11 |
2006-07-20 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
|
|
DK1901749T3
(en)
|
2005-05-18 |
2016-10-24 |
Raptor Pharmaceuticals Inc |
Aerosolized fluoroquinolones AND USES THEREOF
|
|
US8524735B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
EP1844805A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Inhalator
|
|
AU315526S
(en)
|
2006-09-28 |
2007-08-03 |
Glaxo Group Ltd |
Inhalation device
|
|
EP3272379A1
(en)
|
2008-02-07 |
2018-01-24 |
The University of Washington |
Circumferential aerosol device
|
|
CN103190631B
(zh)
|
2008-03-20 |
2016-01-20 |
维尔恩公司 |
非水性预乳液组合物及制备包含植物甾醇的饮料的方法
|
|
AU2009226019C1
(en)
|
2008-03-20 |
2014-02-20 |
Virun, Inc. |
Emulsions including a PEG-derivative of tocopherol
|
|
US8337931B2
(en)
*
|
2008-06-23 |
2012-12-25 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
CA2739893C
(en)
|
2008-10-07 |
2016-10-04 |
Mpex Pharmaceuticals, Inc. |
Inhalation of levofloxacin for reducing lung inflammation
|
|
US8815838B2
(en)
|
2008-10-07 |
2014-08-26 |
David C. Griffith |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
|
CN104523661A
(zh)
|
2009-02-06 |
2015-04-22 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
|
PL2987490T3
(pl)
|
2009-07-15 |
2017-12-29 |
Theravance Biopharma R&D Ip, Llc |
Postacie krystaliczne wolnej zasady związku bifenylowego
|
|
EP3569235A1
(en)
|
2009-09-04 |
2019-11-20 |
Horizon Orphan LLC |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
|
CN102573886A
(zh)
*
|
2009-09-17 |
2012-07-11 |
相互制药公司 |
用抗病毒剂治疗哮喘的方法
|
|
CA2779488A1
(en)
|
2009-11-12 |
2011-05-19 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
|
US10210216B2
(en)
*
|
2009-12-18 |
2019-02-19 |
Sybase, Inc. |
Dynamic attributes for mobile business objects
|
|
US8507734B2
(en)
|
2010-03-03 |
2013-08-13 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising monoterpenes
|
|
CN103037708B
(zh)
|
2010-03-23 |
2015-05-20 |
维尔恩公司 |
含有蔗糖脂肪酸酯的纳米乳液
|
|
WO2011162802A1
(en)
|
2010-06-21 |
2011-12-29 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
FR2962342B1
(fr)
*
|
2010-07-07 |
2013-02-15 |
Valois Sas |
Inhalateur de poudre seche.
|
|
RU2013105007A
(ru)
*
|
2010-07-07 |
2014-08-20 |
Аптар Франс Сас |
Способ применения ингалятора сухого порошка
|
|
FR2962343B1
(fr)
*
|
2010-07-07 |
2012-08-03 |
Valois Sas |
Inhalateur de poudre seche.
|
|
FR2962340B1
(fr)
*
|
2010-07-07 |
2012-08-03 |
Valois Sas |
Inhalateur de poudre seche.
|
|
FR2962337B1
(fr)
*
|
2010-07-07 |
2013-02-15 |
Valois Sas |
Inhalateur de poudre seche.
|
|
FR2962341B1
(fr)
*
|
2010-07-07 |
2013-02-15 |
Valois Sas |
Inhalateur de poudre seche.
|
|
WO2012083178A1
(en)
|
2010-12-17 |
2012-06-21 |
Neo Oncology Inc. |
Methods and devices for using isoperillyl alcohol
|
|
US9499461B2
(en)
|
2010-08-27 |
2016-11-22 |
Neonc Technologies, Inc. |
Pharmaceutical compositions comprising POH derivatives
|
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
|
USD666492S1
(en)
|
2010-11-01 |
2012-09-04 |
Colgate-Palmolive Company |
Cap for a container
|
|
USD666096S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
|
USD666097S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
|
USD666493S1
(en)
|
2010-11-01 |
2012-09-04 |
Colgate-Palmolive Company |
Cap for a container
|
|
USD666099S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
|
USD666098S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
|
JP6050758B2
(ja)
|
2010-12-07 |
2016-12-21 |
レスピラ セラピューティクス インコーポレイテッドＲｅｓｐｉｒａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
乾燥粉末吸入器及びその作動方法
|
|
JP6021117B2
(ja)
|
2011-01-31 |
2016-11-02 |
ジェノア ファーマシューティカルズ，インク． |
エアロゾルのピルフェニドンおよびピリドンアナログの化合物、および、その使用
|
|
CA3111516C
(en)
|
2011-03-03 |
2023-05-23 |
Impel Neuropharma, Inc. |
Nasal drug delivery device
|
|
AU2012253569B2
(en)
|
2011-05-09 |
2018-02-15 |
Impel Pharmaceuticals Inc. |
Nozzles for nasal drug delivery
|
|
FR2977498B1
(fr)
*
|
2011-07-05 |
2015-10-02 |
Valois Sas |
Inhalateur de poudre seche.
|
|
KR102002187B1
(ko)
|
2011-07-13 |
2019-07-19 |
파맥시스 엘티디 |
전달 장치에 관한 개선
|
|
DK2731571T3
(da)
*
|
2011-07-13 |
2020-02-17 |
Pharmaxis Ltd |
Forbedringer vedrørende leveringsanordninger
|
|
WO2013120025A1
(en)
|
2012-02-10 |
2013-08-15 |
Virun, Inc. |
Beverage compositions containing non-polar compounds
|
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
|
US20150343159A1
(en)
|
2012-07-05 |
2015-12-03 |
Glaxo Group Limited |
Inhaler Device
|
|
UA111442C2
(uk)
*
|
2012-10-02 |
2016-04-25 |
Кмс Ді Колозіо Мауро |
Інгаляційний пристрій
|
|
US9764103B2
(en)
*
|
2012-10-05 |
2017-09-19 |
Lily A. Neff |
Salt puffer
|
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
|
CA2909954C
(en)
|
2013-04-28 |
2021-03-23 |
Impel Neuropharma, Inc. |
Medical unit dose container
|
|
US10149823B2
(en)
|
2013-04-30 |
2018-12-11 |
Otitopic Inc. |
Dry powder formulations and methods of use
|
|
US20150044288A1
(en)
|
2013-07-31 |
2015-02-12 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
|
EP4491180A1
(en)
|
2014-01-10 |
2025-01-15 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
|
DK3107548T3
(da)
|
2014-02-20 |
2022-07-18 |
Otitopic Inc |
Tørpulverformuleringer til inhalation
|
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
|
CA2965759C
(en)
|
2014-10-31 |
2023-12-12 |
Glaxosmithkline Intellectual Property Development Limited |
Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials
|
|
EP3244952A4
(en)
|
2015-01-14 |
2018-11-14 |
Respira Therapeutics, Inc. |
Powder dispersion methods and devices
|
|
CN107613768B
(zh)
|
2015-02-12 |
2020-10-20 |
NeOnc技术股份有限公司 |
包含紫苏醇衍生物的药物组合物
|
|
MX2018002895A
(es)
|
2015-09-10 |
2018-07-06 |
Impel Neuropharma Inc |
Dispositivo de administracion nasal en linea.
|
|
BR112018009899A8
(pt)
|
2015-11-18 |
2019-02-26 |
Glaxosmithkline Ip No 2 Ltd |
composição, inalador, forma de dosagem única, métodos para fabricar partículas, para melhorar as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a incidência das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a gravidade das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir uma infecção respiratória viral e para fabricar uma partícula de inalação de pó seco de ribavirina controlada na forma polimorfa cristalina, partículas fabricadas, método de tratamento, pluralidade de partículas, e, recipiente de dose.
|
|
IT201600095707A1
(it)
*
|
2016-09-23 |
2018-03-23 |
Cms Di Colosio Mauro |
Dispositivo inalatore
|
|
IT201600095634A1
(it)
*
|
2016-09-23 |
2018-03-23 |
Cms Di Colosio Mauro |
Dispositivo inalatore
|
|
CN110267538B
(zh)
|
2016-11-30 |
2022-04-19 |
尼昂克技术公司 |
紫苏醇-3-溴丙酮酸缀合物和治疗癌症的方法
|
|
US9731103B1
(en)
|
2017-01-13 |
2017-08-15 |
Berkshire Biomedical, LLC |
Computerized oral prescription administration devices and associated systems and methods
|
|
WO2018174938A1
(en)
|
2017-03-23 |
2018-09-27 |
Virun, Inc. |
Stable dry powders and emulsions containing probiotics and mucoadhesive protein
|
|
US10792226B2
(en)
|
2017-06-07 |
2020-10-06 |
Berkshire Biomedical, LLC |
Refill and dosage management devices and associated systems and methods for use with computerized oral prescription administration devices
|
|
EP3713628A4
(en)
|
2017-11-21 |
2021-08-18 |
Impel Neuropharma Inc. |
INTRA-NASAL DEVICE WITH DIVER TUBE
|
|
CN111372635B
(zh)
|
2017-11-21 |
2022-08-16 |
英倍尔制药公司 |
带有入口接口的鼻内装置
|
|
RU2020125871A
(ru)
|
2018-01-05 |
2022-02-07 |
Импел Ньюрофарма, Инк. |
Интраназальная доставка дигидроэрготамина с помощью прецизионного устройства для доставки в обонятельную область
|
|
AU2019205329B2
(en)
|
2018-01-05 |
2023-04-20 |
Impel Pharmaceuticals Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
|
JP7325425B2
(ja)
|
2018-02-08 |
2023-08-14 |
ネオンク テクノロジーズ インク． |
血液脳関門を透過性にする方法
|
|
US10441509B2
(en)
|
2018-03-16 |
2019-10-15 |
Berkshire Biomedical, LLC |
Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods
|
|
CN112955134A
(zh)
|
2018-07-19 |
2021-06-11 |
英倍尔药业股份有限公司 |
用于治疗帕金森氏病的左旋多巴和多巴脱羧酶抑制剂的呼吸道递送
|
|
CN113473967B
(zh)
|
2019-01-03 |
2022-09-09 |
英倍尔制药公司 |
经鼻药物递送装置
|
|
EP3937957A1
(en)
|
2019-03-14 |
2022-01-19 |
OM Pharma SA |
Process for making stable bacterial extracts and their use as pharmaceuticals
|
|
BR112021018086A2
(pt)
|
2019-03-14 |
2021-11-23 |
Univ Arizona |
Método de tratamento e/ou prevenção de asma, exacerbações de asma, asma alérgica e/ou condições associadas com microbiota relacionadas a distúrbios respiratórios
|
|
WO2020236658A1
(en)
|
2019-05-17 |
2020-11-26 |
Impel Neuropharma, Inc. |
Single-use nasal delivery device
|
|
US10729860B1
(en)
|
2019-05-22 |
2020-08-04 |
Berkshire Biomedical, LLC |
Computerized oral prescription administration for securely dispensing a medication and associated systems and methods
|
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|
|
JP2025513460A
(ja)
|
2022-04-22 |
2025-04-24 |
クエンチ メディカル インコーポレイテッド |
粉末吸入による医薬品の送達
|
|
WO2023232976A1
(en)
|
2022-06-03 |
2023-12-07 |
Ags Therapeutics Sas |
Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses
|